Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LACI-Cog-1
ISRCTN84539143Phase 2Recruiting
- Sponsor
- University of Edinburgh
- Start
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of isosorbide mononitrate and cilostazol in vascular cognitive disorder (VCD) and Cerebral Small Vessel Disease (CSVD) (4 arms), sponsored by University of Edinburgh. Primary endpoint: Primary endpoint not reported. Started Jun 2026; status: recruiting.
02
Drugs
isosorbide mononitratecilostazol
03
Conditions
vascular cognitive disorder (VCD)Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on ISRCTN84539143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN84539143.